Jan 12 (Reuters) - Revvity said on Monday it expects its 2025 adjusted profit per share to exceed its forecast of $4.90 to $5, as the medical equipment maker benefits from renewed demand for contract research and diagnostics services.
The company's shares were up nearly 6% in extended trading.
Pharmaceutical companies have ramped up drug development in the U.S. amid evolving trade policies under President Donald Trump.
Revvity said it expects to report fourth-quarter revenue of around $772 million, above Wall Street estimates of $760.3 million, according to data compiled by LSEG.
It also expects annual revenue to grow 4% to $2.86 billion, above estimates of $2.84 billion.
The company will report its fourth-quarter and full year 2025 results on February 2.
(Reporting by Puyaan Singh in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima - 2An Artemis 2 astronaut took a 'bath' on camera on the way to the moon. Mission Control's reaction was priceless (video)
- 3Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- 4Why is the Artemis 2 rocket launch different from all other rocket launches?
- 5Doctored NXT Summit footage falsely portrays Modi as declaring war on Iran and Pakistan
- Broken toilet, T-shirts on windows and collecting saliva: The weirdness of daily life aboard Orion
- Satellite constellations could obscure most space telescope observations by late 2030s: 'That part of the image will be forever lost'
- Nutrient Rich Natural products: Lift Your Wellbeing
- Schools to start reopening after Nigeria mass abduction
- Unpaid caregiving work can feel small and personal, but that doesn’t take away its ethical value
- Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
- 4 Coolers for Present day Kitchens
- One third of Spanish pork export certificates blocked since swine fever outbreak, minister says
- Step by step instructions to Guarantee the Life span of Your Dental Inserts: Support and Care Guide
